Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trazodone prolonged-release in depression
NCT01524497Phase 3Completed
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Nov 2011
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trazodone hydrochloride prolonged-release tablets in major depressive disorder (MDD), sponsored by Lee's Pharmaceutical Holdings Limited. Started Nov 2011; status: completed.
02
Drugs
trazodone hydrochloride prolonged-release tablets
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01524497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01524497.